CHAMP App Cardiac Study and Repository
Launched by LORI ERICKSON · Sep 11, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Study objectives
1. To evaluate whether data collection and transmission through the CHAMP software platform improves communication between health care providers and parents/LAR that positively affects the care of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated
2. To determine the accuracy of data obtained regarding observation by parent or caregiver of the condition of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
3. To evaluate the use of the CHAMP App for ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 0-17 years with a parent/Legally authorized representative
- • Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate.
- • Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring.
- • Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City.
- • Adult participants
- • Parents/Legally authorized representatives of pediatric subject.
- • Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City.
- Exclusion Criteria:
- • Inability to be discharged to care in the home setting.
- • Those not meeting the above inclusion criteria.
About Lori Erickson
Lori Erickson is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, Lori collaborates with healthcare professionals and research institutions to design, implement, and oversee clinical trials that adhere to the highest ethical standards and regulatory guidelines. Her expertise in clinical trial management, combined with a patient-centered approach, ensures the efficient execution of studies while prioritizing participant safety and data integrity. Through her leadership, Lori aims to contribute to the development of groundbreaking treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
New Orleans, Louisiana, United States
Columbus, Ohio, United States
Houston, Texas, United States
Washington, District Of Columbia, United States
Cincinnati, Ohio, United States
Salt Lake City, Utah, United States
Miami, Florida, United States
Forth Worth, Texas, United States
Patients applied
Trial Officials
Lori Erickson, PhD
Principal Investigator
Director, Remote Health Solutions Children's Mercy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported